CLOSE

Specials

  • March
  • June
  • September
  • Bioanalytical Services
  • Life Science Analytics
  • Life Science Compliance
  • Bioanalytical Services APAC
  • APAC
  • Europe

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Tollys Makes Philippe Goupit as Chairman of the Board

Tollys Makes Philippe Goupit as...

Immudex Releases dCode Dextramer Reagants

Immudex Releases dCode Dextramer...

How Biomarkers Impact Drug Discovery and Development

How Biomarkers Impact Drug Discovery...

Why is Liquid Chromatography Coupled with Mass Spectrometry (LC-MS) Favored for Pharmaceutical Bioanalysis?

Why is Liquid Chromatography Coupled...

Clinical Potential of Combining AI and Decentralized Clinical Trials

Clinical Potential of Combining AI...

Proactive Strategies to Keep Container Fleet Intact

Proactive Strategies to Keep...

Improving Access to Quality and Critical Care through Telemedicine

Improving Access to Quality and...

Bioanalytics- A New Ray of Hope

Bioanalytics- A New Ray of Hope

Tollys Makes Philippe Goupit as Chairman of the Board

Tollys Makes Philippe Goupit as...

Immudex Releases dCode Dextramer Reagants

Immudex Releases dCode Dextramer...

How Biomarkers Impact Drug Discovery and Development

How Biomarkers Impact Drug Discovery...

Why is Liquid Chromatography Coupled with Mass Spectrometry (LC-MS) Favored for Pharmaceutical Bioanalysis?

Why is Liquid Chromatography Coupled...

Clinical Potential of Combining AI and Decentralized Clinical Trials

Clinical Potential of Combining AI...

Proactive Strategies to Keep Container Fleet Intact

Proactive Strategies to Keep...

Improving Access to Quality and Critical Care through Telemedicine

Improving Access to Quality and...

Bioanalytics- A New Ray of Hope

Bioanalytics- A New Ray of Hope

Tecan Partners with QIAGEN to Automate Pre-analytical Processing of Blood Samples

By Life Sciences Review Life Sciences Review | Friday, January 29, 2021
Tweet

Tecan has introduced the Fluent Mix and Pierce Workstation, a newly designed instrument design that is expected to standardize pre-analytical samples' processing and mixing. 


FREMONT, CA: Tecan has introduced the Fluent Mix and Pierce Workstation in order to provide end-to-end automation for full blood pipetting in clinical settings. The newly designed instrument design is expected to standardize the processing and mixing of pre-analytical samples. It is part of an ongoing collaboration with QIAGEN to improve sample preparation with the QuantiFERON-TB Gold Plus assay for latent tuberculosis (TB) research.


Using a Flexible Channel Arm fitted with Tecan Piercing Tips to aliquot whole blood samples directly from vacuum blood collection tubes or septum-capped tubes without the requirement of manual lid removal, the Fluent Mix and Pierce Workstation provides a fully automated workflow. It eliminates the risk of infectious materials encountering laboratory workers and saves precious time when tube-to-tube or tube-to-plate transfers and whole blood assays are performed. The newly designed Tecan Tube Rotator also includes the workstation, which offers 360-degree tube mixing to hold entire blood samples in suspension without hemolysis. It offers barcode scanning for both primary and secondary tubes to ensure complete process traceability for clinical settings.


Dr. Klaus Lun, Executive Vice President and Head of the Life Sciences Business Division at Tecan, stated: "Our vision at Tecan is to empower every laboratory, every day, around the world, and we are delighted to collaborate with QIAGEN – a global leader in the important area of modern latent TB detection – to help even more labs to increase productivity and reduce processing errors through automation of tedious manual steps."


Jean-Pascal Viola, Senior Vice President, Head of the Molecular Diagnostics Business Area and Corporate Business Development at QIAGEN NV, added: "We are pleased to expand our collaboration with Tecan – a proven leader with a track record of providing best-in-class liquid handling technology solutions – to further improve the automation of pre-analytical whole blood processing. This partnership will greatly accelerate the adoption and ease of processing of single-tube samples for latent TB detection."


Weekly Brief

loading
Towards a New World Order
> <
  • Other 2021

    Top Vendors

    Current Issue
  • Other 2020

    Top Vendors

    Current Issue

Read Also

Top Biotech Developments to Watch for

Top Biotech Developments to Watch for

Importance of Biomarkers in Drug Development

Importance of Biomarkers in Drug Development

Using AI to Prevent Adverse Effects of Immunotherapy

Using AI to Prevent Adverse Effects of Immunotherapy

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care

Ehave, Inc. Uses Artificial Intelligence And Machine Learning for Big Data Management in Mental Health Care
The Role of Technology in the Biotech Sector

The Role of Technology in the Biotech Sector

Why Partner with Bioanalysis Experts?

Why Partner with Bioanalysis Experts?

Cyberattacks in Hospitals

Cyberattacks in Hospitals

Principles of Sustainability in Pharmaceutical Packaging

Principles of Sustainability in Pharmaceutical Packaging
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/tecan-partners-with-qiagen-to-automate-preanalytical-processing-of-blood-samples-nwid-239.html